Literature DB >> 11204573

Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight.

I Laude1, C Rongières-Bertrand, C Boyer-Neumann, M Wolf, V Mairovitz, B Hugel, J M Freyssinet, R Frydman, D Meyer, V Eschwège.   

Abstract

One of the frequently proposed mechanisms for pregnancy losses refers to uteroplacental thrombosis. However the contribution of classical thrombotic risk factors remains questionable and, if real, does not account for a large number of pregnancy losses. The aim of this study was to investigate the presence of circulating procoagulant microparticles, a new marker of cell activation already associated with various prothrombotic clinical settings. Microparticles were assessed by an original prothrombinase assay on platelet depleted plasma obtained from 74 women with a history of pregnancy loss without apparent cause and 50 controls. Patients were studied at least 2 months after the last obstetrical event and were classified into 2 groups: 49 women with at least 3 consecutive spontaneous abortions at or before the 10th postmenstrual week and 25 with at least one fetal death beyond the 10th postmenstrual week. Among the 74 patients, 41 had increased levels of circulating microparticles, 29 belonging to the group of early pregnancy loss (59%) and 12 to the group of late pregnancy loss (48%). The high prevalence of increased levels of procoagulant microparticles in both groups makes this new marker very promising for the understanding, follow up and therapeutical handling of pregnancy loss.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204573

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  Oxidative stress and antioxidant defenses in pregnant women.

Authors:  Claudio A M Leal; Maria R C Schetinger; Daniela B R Leal; Vera M Morsch; Aleksandro Schafer da Silva; João F P Rezer; André Valle de Bairros; Jeandre Augusto Dos Santos Jaques
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

2.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

3.  Profibrinolytic microparticles are not adequately produced to compensate their prothrombotic effect.

Authors:  Rucha Patil; Kanjaksha Ghosh; Shrimati Shetty
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

4.  Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial.

Authors:  Elisabeth Pasquier; Luc de Saint Martin; Caroline Bohec; Céline Chauleur; Florence Bretelle; Gisèle Marhic; Grégoire Le Gal; Véronique Debarge; Frédéric Lecomte; Christine Denoual-Ziad; Véronique Lejeune-Saada; Serge Douvier; Michel Heisert; Dominique Mottier
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

Review 5.  Extracellular vesicles and their immunomodulatory functions in pregnancy.

Authors:  Soumyalekshmi Nair; Carlos Salomon
Journal:  Semin Immunopathol       Date:  2018-04-03       Impact factor: 9.623

Review 6.  Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage.

Authors:  Claire de Moreuil; Zarrin Alavi; Elisabeth Pasquier
Journal:  Br J Clin Pharmacol       Date:  2019-12-17       Impact factor: 4.335

Review 7.  Extracellular vesicles and immune response during pregnancy: A balancing act.

Authors:  Adrian E Morelli; Yoel Sadovsky
Journal:  Immunol Rev       Date:  2022-02-23       Impact factor: 10.983

Review 8.  Anticoagulants in pregnancy.

Authors:  Ian A Greer
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

9.  Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.

Authors:  Xuejiao Li; Yukun Liu; Rui Zhang; Jianping Tan; Libin Chen; Yinglin Liu
Journal:  Med Sci Monit       Date:  2015-04-11

10.  Antioxidative defense enzymes in placenta protect placenta and fetus in inherited thrombophilia from hydrogen peroxide.

Authors:  Jelena Bogdanovic Pristov; Ivan Spasojevic; Zeljko Mikovic; Vesna Mandic; Nikola Cerovic; Mihajlo Spasic
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.